FIRMQUARRYResearch workspace

US_FEDERAL process · buyer country US · award

PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

Department of Health and Human Services

Procedure CONT_AWD_75F40123P00450_7524_-NONE-_-NONE-CPV 325413Other
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
Buyer identifier
Not reported
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
Not reported
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

    US · usaspendingSource ↗
  2. Value increased

    PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.

    US · usaspending$17.5KSource ↗

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched